Samuel Louis Participates in Televised Briefing to Congressional Aides on Foreign Importation of Drugs
Clark Hill Strasburger's Samuel Louis – a member of the firm's Healthcare group, Food and Drug Law group and White Collar group – was in Washington, D.C. on January 31, 2019, participating in a conference to brief congressional aides concerning potential issues with foreign importation of drugs. Sam is serving on a panel with experts from law enforcement, pharmacy boards and academia involved in the pharmaceutical supply chain.
A Houston-based attorney, Louis's practice involves providing advice and counsel regarding healthcare regulatory issues, white collar criminal defense, corporate internal investigations, FCPA and compliance with federal regulations that govern food and drug distribution. He has extensive experience representing corporate entities, their executives and employees in connection with grand jury investigations, criminal trials and hearings, regulatory investigation and enforcement proceedings, federal criminal prosecutions, Food, Drugs and Cosmetic Act investigations and prosecutions, False Claims Act and Healthcare Fraud investigations.
Religious Accommodations Update: What Manufacturers Need To KnowExplore more
Right To Know - November 30, 2022, Vol. 1
Cyber, Privacy, and Technology Report
FERC Advancing New Reliability Requirements for Renewables
The Federal Energy Regulatory Commission (FERC) recently issued two orders designed to address electric grid reliability implications raised by the dramatic growth in solar and wind projects. Renewable project owners and operators should follow these developments closely, as FERC’s orders propose to substantially increase registration and compliance requirements.